| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.024 | 0.7 |